ARROWHEAD PHARMACEUTICALS, INC. Noncontrolling Interest, Decrease from Deconsolidation
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Noncontrolling Interest, Decrease from Deconsolidation of $555.00 thousand for the 12-month period ending 2020-09-30, per its 10-K filed 2021-11-22.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2021-11-22
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from deconsolidation for the quarter ending 2014-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from deconsolidation for fiscal 2020 was $555.00K.
- ARROWHEAD PHARMACEUTICALS, INC. noncontrolling interest, decrease from deconsolidation for fiscal 2014 was $1.30M.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 9 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month as first filed |
|---|---|---|---|---|
| 2020-09-30 | $555.00K 10-K · filed 2021-11-22 | $555.19K 10-K · filed 2020-11-23 | ||
| 2014-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $1.30M 10-K · filed 2016-12-14 | ||
| 2014-06-30 | $1.30M 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |